Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Income Statement [Abstract] | ||||||
| REVENUES | ||||||
| OPERATING EXPENSES FROM CONTINUED OPERATIONS | ||||||
| Payroll and related expenses | 540,450 | 192,912 | 5,555,471 | 608,029 | 372,938 | 650,160 |
| Professional fees | 473,017 | 173,279 | 1,427,703 | 327,961 | 442,795 | 437,282 |
| General and administrative | 18,839 | 16,884 | 64,887 | 121,692 | 146,207 | 42,251 |
| Research and development expenses | 164,378 | 96,943 | 385,785 | 206,943 | 362,456 | |
| Total Operating Expenses | 1,196,684 | 480,018 | 7,433,845 | 1,264,625 | 1,324,396 | 1,129,693 |
| LOSS FROM CONTINUING OPERATIONS | (1,196,684) | (480,018) | (7,433,845) | (1,264,625) | (1,324,396) | (1,129,693) |
| OTHER INCOME (EXPENSE) FROM CONTINUING OPERATIONS | ||||||
| Financing costs including interest | (450) | (153,628) | (38,978) | (431,790) | (490,402) | (540,877) |
| Change in fair value of convertible bridge notes | (1,343,236) | (1,666,422) | (3,170,236) | 1,057,877 | ||
| Other miscellaneous income | 5,000 | |||||
| Loss on equity method investment | 100,000 | (21,588) | ||||
| Loss on convertible debt and other liabilities converted to equity | (390,068) | (834,903) | ||||
| Gain on forgiveness of debt from Paycheck Protection Program | 142,942 | 142,942 | ||||
| Loss on conversion of bridge notes including accrued interest and debt forgiveness | (503,762) | (744,505) | (503,762) | |||
| Total Other (Expense) Income | 142,492 | (2,000,627) | (930,609) | (2,596,974) | (4,495,541) | 495,412 |
| Loss from continuing operations before income taxes | (1,054,192) | (2,480,645) | (8,364,454) | (3,861,599) | (5,819,937) | (634,281) |
| INCOME TAXES | ||||||
| Loss from continuing operations | (1,054,192) | (2,480,645) | (8,364,454) | (3,861,599) | (5,819,937) | (634,281) |
| DISCONTINUED OPERATIONS: | ||||||
| Income (Loss) from discontinued operations before income taxes | 56,056 | 126,964 | 957,254 | (47,698) | ||
| INCOME TAXES | ||||||
| Income (Loss) from discontinued operations | 56,056 | 126,964 | 957,254 | (47,698) | ||
| NET LOSS | (1,054,192) | (2,424,588) | (8,364,454) | (3,734,635) | (4,862,683) | (681,979) |
| PREFERRED STOCK | ||||||
| Series A convertible contractual dividends | (870,204) | (9,074) | (1,583,421) | (26,366) | (35,440) | (36,000) |
| NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS | $ (1,924,396) | $ (2,433,633) | $ (9,947,875) | $ (3,761,001) | $ (4,898,123) | $ (717,979) |
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC AND DILUTED: | ||||||
| CONTINUING OPERATIONS | $ (0.06) | $ (1.05) | $ (0.36) | $ (1.69) | $ (1.06) | $ (0.32) |
| DISCONTINUED OPERATIONS | 0.02 | 0.06 | 0.17 | (0.02) | ||
| Earnings Per Share, Basic and Diluted | $ (0.06) | $ (1.03) | $ (0.37) | $ (1.64) | $ (0.88) | $ (0.34) |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED | 31,452,858 | 2,365,613 | 27,318,388 | 2,296,748 | 5,522,771 | 2,079,898 |
| X | ||||||||||
- Definition Change in fair value of convertible bridge notes. No definition available.
|
| X | ||||||||||
- Definition Gain loss on conversion of bridge notes including accrued interest and debt forgiveness. No definition available.
|
| X | ||||||||||
- Definition Gain loss on debentures and accrued expenses converted to common stock. No definition available.
|
| X | ||||||||||
- Definition Gain on forgiveness of debt from paycheck protection program. No definition available.
|
| X | ||||||||||
- Definition Other miscellaneous income. No definition available.
|
| X | ||||||||||
- Definition Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition This element represents interest incurred for borrowed money which was used to produce goods or render services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation, when the per share amount is the same. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends). No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|